|
ELTP Elite Pharmaceuticals, Inc. Common Stock 1053369 |
| Balance Sheet |
|
Current Assets
|
$112,106,551.00 |
|
Assets
|
$138,289,840.00 |
|
Current Liabilities
|
$17,391,464.00 |
|
Liabilities
|
$39,406,865.00 |
|
Equity
|
$98,882,975.00 |
|
Shares Out
|
1077096442.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$23,748,094.00 |
|
Investing Cash Flow
|
$-925,626.00 |
| Market Analysis |
Market Cap
|
$398,525,683.54 |
|
Price
|
$0.37 |
|
BVPS
|
0.09 |
|
PB
|
4.11 |
|
EPS
|
0.04 |
|
PE
|
10.21 |
|
PS
|
2.46 |
|
FCF
|
$22,822,468.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:27 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-17 |
0.01 |
|
| Jul |
Aug |
Sep |
| 2026-06-29 |
0.03 |
|
|
2025-08-14 |
-0.01 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
0.01 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ELTP documents filed with the SEC.
ELTP Filings
Clear
